Word

GLYCOEXPRESS

Status

Dead

Status Code

709

Status Date

Friday, January 28, 2022

Serial Number

79068784

Registration Number

3991708

Registration Date

Tuesday, July 12, 2011

Mark Type

4000

Filing Date

Thursday, November 27, 2008

Published for Opposition

Tuesday, April 26, 2011

Cancellation Date

Friday, January 28, 2022

Trademark Owner History

Glycotope GmbH - Original Registrant

Classifications

5 [Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; medicines for human and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzyme, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof for use in the prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes for human or animals, namely, nutritional additives in the nature of enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements]

1 [Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilizing preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and respective preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic preparations, other than for medical purposes; carbohydrates used as an ingredient or as an integral component in food or nutraceuticals; cultures of microorganisms and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms and cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; gene expression systems for proteins and peptides, particularly on the basis of cells, particularly human cells and microorganisms, namely, gene expression systems comprising biochemicals, assays, and reagents for use in manufacturing engineered or glycosylated proteins or peptides and for scientific research, gene expression systems comprising biochemicals, assays and reagents with optimized glycosylation activity for use in manufacturing proteins or peptides, in particular engineered or glycosylated proteins or peptides, and for scientific research; milk ferments for medical research purposes]

42 Scientific and technological services, namely, [bacteria and] cell engineering services, [bacteria and] cell cultivation and harvesting services, research and development related to protein production, glycosylation, optimization of protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; research and design services in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; [design and development of computer hardware and software;] biological research; services of a [chemical or] biological laboratory; [technical surveys, namely, conducting biotechnology surveys, pharmacology surveys; conducting scientific surveys in the field of biotechnology, bacterial and cell engineering, protein production, glycosylation;] research and development in the field of [bacteriology, ]cytology, antibody technology, [chemistry, immunology, cosmetics of expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control;] research and development of new products and technologies in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity,[ bacteria and] cell engineering, cultivation and harvesting for others; technology and scientific consultancy in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines [and microorganisms,] antibody-engineering, optimized biological therapeutics; [nutraceuticals, and food and nutritional supplements;] research, [quality control,] technology consultancy and product development in the field of proteins, antibodies, [microorganisms] and cells; research and development in the field of [microorganisms and] cells

GLYCOTOPE EXPRESS; GLYCOMICS EXPRESS

Trademark Events

Nov 6, 2022

Total Invalidation Processed By The Ib

Oct 6, 2022

Total Invalidation Of Reg Ext Protection Sent To Ib

Oct 6, 2022

Invalidation Processed

Sep 28, 2022

Total Invalidation Of Reg Ext Protection Created

Jan 28, 2022

Cancelled Section 71

Jul 12, 2020

Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed

Dec 16, 2019

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 16, 2019

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 27, 2018

International Registration Renewed

Oct 19, 2018

Partial Invalidation Processed By The Ib

Sep 13, 2018

Partial Invalidation Of Reg Ext Protection Sent To Ib

Sep 13, 2018

Invalidation Processed

Sep 3, 2018

Partial Invalidation Of Reg Ext Protection Created

Jul 27, 2017

Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed

Jul 27, 2017

Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.

Jul 22, 2017

Case Assigned To Post Registration Paralegal

Jul 6, 2017

Teas Section 71 & 15 Received

Dec 14, 2013

New Representative At Ib Received

Mar 3, 2013

Final Decision Transaction Processed By Ib

Jan 6, 2012

Final Disposition Notice Sent To Ib

Jan 5, 2012

Final Disposition Processed

Oct 12, 2011

Final Disposition Notice Created, To Be Sent To Ib

Jul 12, 2011

Registered-Principal Register

Apr 26, 2011

Official Gazette Publication Confirmation E-Mailed

Apr 26, 2011

Published For Opposition

Apr 23, 2011

Notification Of Possible Opposition - Processed By Ib

Apr 6, 2011

Notification Of Possible Opposition Sent To Ib

Apr 6, 2011

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 22, 2011

Law Office Publication Review Completed

Mar 22, 2011

Exparte Appeal Terminated

Mar 21, 2011

Approved For Pub - Principal Register

Mar 21, 2011

Examiner's Amendment Entered

Mar 21, 2011

Notification Of Examiners Amendment E-Mailed

Mar 21, 2011

Examiners Amendment E-Mailed

Mar 21, 2011

Examiners Amendment -Written

Mar 11, 2011

Notification Of Action Denying Req For Recon E-Mailed

Mar 11, 2011

Action Denying Req For Recon E-Mailed

Mar 11, 2011

Action Continuing Final - Completed

Mar 5, 2011

Notification Of Possible Opposition - Processed By Ib

Feb 17, 2011

Notification Of Possible Opposition Sent To Ib

Feb 17, 2011

Notification Of Possible Opposition Created, To Be Sent To Ib

Feb 14, 2011

Ex Parte Appeal-Instituted

Feb 14, 2011

Jurisdiction Restored To Examining Attorney

Feb 14, 2011

Exparte Appeal Received At Ttab

Feb 2, 2011

Teas/Email Correspondence Entered

Feb 2, 2011

Correspondence Received In Law Office

Jan 31, 2011

Assigned To Lie

Jan 31, 2011

Teas Request For Reconsideration Received

Oct 28, 2010

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 28, 2010

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 12, 2010

Final Refusal Mailed

Aug 11, 2010

Final Refusal Written

Jul 27, 2010

Teas/Email Correspondence Entered

Dec 22, 2009

Correspondence Received In Law Office

Jan 21, 2010

Limitation From The Ib Examined, No Action Is Needed

Jan 21, 2010

Limitation Of Goods Received From Ib

Jan 5, 2010

Limitation Of Goods/Services From Ib Entered

Dec 22, 2009

Teas Response To Office Action Received

Nov 30, 2009

Limitation Of Goods Received From Ib

Oct 17, 2009

Attorney Review Completed

Sep 25, 2009

Correction From Ib Entered - Attorney Review Required

Sep 19, 2009

Refusal Processed By Ib

Sep 18, 2009

Correction Transaction Received From Ib

Jun 26, 2009

Non-Final Action Mailed - Refusal Sent To Ib

Jun 26, 2009

Refusal Processed By Mpu

Jun 26, 2009

Non-Final Action (Ib Refusal) Prepared For Review

Jun 25, 2009

Non-Final Action Written

Jun 23, 2009

Application Filing Receipt Mailed

Jun 19, 2009

Assigned To Examiner

Jun 19, 2009

New Application Office Supplied Data Entered In Tram

Jun 18, 2009

Sn Assigned For Sect 66a Appl From Ib